RaminFarzaneh-FarMD
Cardiology • Dallas, TXAdult Congenital Heart Disease
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Are you Dr. Farzaneh-Far?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ut Southwestern Medical Ctr
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-7500
Summary
- Dr. Ramin Farzaneh-Far, MD is a cardiologist in Dallas, Texas. He is currently licensed to practice medicine in Texas and California. He is an Assistant Professor at University of Texas Southwestern Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 2006 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2005
Royal Free Hospital and University College London Medical SchoolClass of 2002
Certifications & Licensure
CA State Medical License 2006 - 2026
TX State Medical License 2011 - 2014
Clinical Trials
- Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease Start of enrollment: 2015 Dec 01
- Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 80 citationsA functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.Ramin Farzaneh-Far, Gary V. Desir, Beeya Na, Nelson B. Schiller, Mary A. Whooley
Plos One. 2010-10-20 - 109 citationsPhysical Fitness and Risk for Heart Failure and Coronary Artery DiseaseJarett D. Berry, Ambarish Pandey, Ang Gao, David Leonard, Ramin Farzaneh-Far
Circulation. Heart Failure. 2013-07-01 - 20 citationsUse of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel ...Ramin Farzaneh-Far, Ori Ben-Yehuda, Bernard deBruyne, Gilles Montalescot, Amir Lerman
American Heart Journal. 2013-12-01
Press Mentions
Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 ProgramAugust 8th, 2018
Ra Pharmaceuticals Initiates Phase 1b Trial of New Therapy for Lupus NephritisJanuary 9th, 2018
